KRW 9790.0
(-4.39%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - KRW | 0.0% |
2022 | - KRW | 0.0% |
2021 | - KRW | 0.0% |
2020 | - KRW | 0.0% |
2019 | - KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - KRW | 0.0% |
2024 Q1 | - KRW | 0.0% |
2023 FY | - KRW | 0.0% |
2023 Q4 | - KRW | 0.0% |
2023 Q3 | - KRW | 0.0% |
2023 Q2 | - KRW | 0.0% |
2023 Q1 | - KRW | 0.0% |
2022 Q2 | - KRW | 0.0% |
2022 Q1 | - KRW | 0.0% |
2022 Q3 | - KRW | 0.0% |
2022 Q4 | - KRW | 0.0% |
2021 Q3 | - KRW | 0.0% |
2021 Q4 | - KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Co., Ltd. | 11.42 Billion KRW | 100.0% |
iNtRON Biotechnology, Inc. | 1.01 Billion KRW | 100.0% |
BINEX Co., Ltd. | 28.26 Billion KRW | 100.0% |
Bioneer Corporation | 41.35 Billion KRW | 100.0% |
Anterogen.Co.,Ltd. | 1.91 Billion KRW | 100.0% |
MEDIPOST Co., Ltd. | 14.51 Billion KRW | 100.0% |
CrystalGenomics, Inc. | 1.55 Billion USD | 100.0% |
Helixmith Co., Ltd | 914.11 Million KRW | 100.0% |
Chabiotech Co.,Ltd. | 34.11 Billion KRW | 100.0% |
Medy-Tox Inc. | 59.61 Billion KRW | 100.0% |
Peptron, Inc. | 172.18 Million KRW | 100.0% |
Amicogen, Inc. | 46.83 Billion KRW | 100.0% |
Genexine, Inc. | 3.8 Billion KRW | 100.0% |
HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | 100.0% |
LegoChem Biosciences, Inc. | 196.83 Million KRW | 100.0% |
ALTEOGEN Inc. | 1.06 Billion KRW | 100.0% |
PharmaResearch Co., Ltd. | 50.23 Billion KRW | 100.0% |
SillaJen, Inc. | 1.21 Billion KRW | 100.0% |
JETEMA, Co., Ltd. | 12.74 Billion KRW | 100.0% |
OliX Pharmaceuticals,Inc | 468.4 Million KRW | 100.0% |
Genomictree Inc. | 496.53 Million KRW | 100.0% |
MedPacto, Inc. | 620.00 KRW | 100.0% |
D&D Pharmatech | 3.45 Billion KRW | 100.0% |
EASY BIO,Inc. | 25.93 Billion KRW | 100.0% |